MUSCULOSKELETAL TRANSPLANT FOUNDATION INC: Form 990, tax year 2020
View the entire original 990 at ProPublica ↗
- Organization
- MUSCULOSKELETAL TRANSPLANT FOUNDATION INC (EIN 22-2803458)
- Tax period
- 2020-01-01 to 2020-12-31
- Filed
- 2021-11-15
- IRS object ID
- 202143199349316744
- Schema version
- 2020v4.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2021-11-15T14:04:51-06:00 | ReturnTs |
| Tax Period End | 2020-12-31 | TaxPeriodEndDt |
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2020-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 222803458 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MUSCULOSKELETAL TRANSPLANT | BusinessNameLine1Txt |
| Business Name Line2 | FOUNDATION INC | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | MUSC | BusinessNameControlTxt |
| Phone | 7326610202 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 125 MAY STREET | AddressLine1Txt |
| City | EDISON | CityNm |
| State Abbreviation | NJ | StateAbbreviationCd |
| ZIP | 088373264 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MICHAEL J KAWAS | PersonNm |
| Person Title | TREASURER/CFO | PersonTitleTxt |
| Phone | 7326610202 | PhoneNum |
| Signature | 2021-11-15 | SignatureDt |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | MICHAEL | PersonFirstNm |
| Person Last | KAWAS | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2020 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MTFBIOLOGICS | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | JOSEPH A YACCARINO | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 125 MAY ST | AddressLine1Txt |
| City | EDISON | CityNm |
| State Abbreviation | NJ | StateAbbreviationCd |
| ZIP | 08837 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $422,495,708 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.MTFBIOLOGICS.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1987 | FormationYr |
| Legal Domicile State | DC | LegalDomicileStateCd |
| Activity Or Mission | MTF IS A NONPROFIT ORG. THAT SAVES AND HEALS LIVES BY HONORING DONATED GIFTS AND SERVING PATIENTS, WE COLLABORATE WITH THE MEDICAL, SCIENTIFIC, AS WELL AS ORGAN AND TISSUE DONATION COMMUNITIES. CONTINUED ON SCHEDULE O. | ActivityOrMissionDesc |
| Voting Members Governing Body | 11 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 10 | VotingMembersIndependentCnt |
| Total Employee | 1462 | TotalEmployeeCnt |
| Total Volunteers | 14 | TotalVolunteersCnt |
| Total Gross UBI | -$8,661,981 | TotalGrossUBIAmt |
| PY Contributions Grants | $890,250 | PYContributionsGrantsAmt |
| CY Contributions Grants | $874,610 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $452,689,157 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $412,031,487 | CYProgramServiceRevenueAmt |
| PY Investment Income | $987,643 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,522,503 | CYInvestmentIncomeAmt |
| PY Other Revenue | $6,261,582 | PYOtherRevenueAmt |
| CY Other Revenue | -$2,799,882 | CYOtherRevenueAmt |
| PY Total Revenue | $460,828,632 | PYTotalRevenueAmt |
| CY Total Revenue | $411,628,718 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $1,929,239 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $644,713 | CYGrantsAndSimilarPaidAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $129,997,127 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $129,297,731 | CYSalariesCompEmpBnftPaidAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $321,177,873 | PYOtherExpensesAmt |
| CY Other Expenses | $285,806,748 | CYOtherExpensesAmt |
| PY Total Expenses | $453,104,239 | PYTotalExpensesAmt |
| CY Total Expenses | $415,749,192 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $7,724,393 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$4,120,474 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $269,396,199 | TotalAssetsBOYAmt |
| Total Assets EOY | $265,715,338 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $206,446,084 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $199,479,606 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $62,950,115 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $66,235,732 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF- OR THE "FOUNDATION") IS DEDICATED TO PROVIDING QUALITY ALLOGRAFT TISSUE FOR TRANSPLANTATION THROUGH A COMMITMENT TO EXCELLENCE IN EDUCATION, RESEARCH, RECOVERY, AND CARE FOR RECIPIENTS, DONORS AND THEIR FAMILIES. MTF CONTINUES TO PROMOTE THE HEALTH AND WELFARE OF THE GENERAL PUBLIC BY (1) MAXIMIZING THE AVAILABILITY OF HIGH QUALITY HUMAN TISSUE INCLUDING BONE, DERMAL AND BIRTH TISSUE; 2) SUPPORTING MEDICAL, SCIENTIFIC AND OTHER EDUCATIONAL RESEARCH WITH RESPECT TO TISSUE DONATION, RECOVERY AND TRANSPLANTATION; AND(3) EDUCATING THE GENERAL PUBLIC WITH RESPECT TO THE IMPORTANCE AND BENEFITS OF TISSUE DONATION AND TRANSPLANTATION. THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. WAS INCORPORATED ON JANUARY 30, 1987, AS A DISTRICT OF COLUMBIA NON- PROFIT MEMBERSHIP ORGANIZATION AND IS A 501(C)(3)ORGANIZATION. THERE IS A CRITICAL NEED FOR MUSCULOSKELETAL, CARDIOVASCULAR, SKIN, BIRTH AND OCULAR TISSUE FOR TRANSPLANTATION. IN ORDER TO ACCOMPLI | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $393,280,876 | ExpenseAmt |
| Grant | $644,713 | GrantAmt |
| Revenue | $413,313,331 | RevenueAmt |
| Desc | MTF PROVIDES ALLOGRAFT TISSUES TO THE MEDICAL COMMUNITY. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 150,000 DONORS. IN 2020, MTF RECOVERED TISSUE FROM OVER 5,500 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 6,300 DONORS FOR USE IN BURN, GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 1,100 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 683 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED APPROXIMATELY 400,000 UNITS OF ALLOGRAFT TISSUE DURING 2020. IN ADDITION TO THE FURTHERANCE OF THE MISSION DRIVEN RESULTS IN 2019 (HIGHLIGHTED BELOW) AND GIVEN THE CHALLENGES FACED IN 2020, MTF CONTINUES TO DEVELOP INNOVATIVE TISSUE FORMS, FOCUSED ON SOLVING REAL-WORLD, CLINICAL PROBLEMS. MTF HAS ALSO CONTINUED ITS EFFORTS TO PROVIDE SPECIAL RESEARCH TISSUE FOR RESEARCH PERFORMED BY MEMBERS OF THE ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE, AN ORGANIZATION DEDICATED TO DEVELOPING MEDICAL THERAPIES FOR WOUNDED SOLDIERS. MTF CONTINUED TO MAKE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS. IN THE ORTHOPEDICS FRANCHISE, MTF DEVELOPED NEW PARTNERSHIPS, FURTHER ENHANCING ITS OUTREACH, DISTRIBUTION NETWORK, AND ABILITY TO BRING DONATED ALLOGRAFT TISSUES TO PATIENT RECIPIENTS. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY FRANCHISE, MTF DEVELOPED STRATEGIC INTER-INDUSTRY PARTNERSHIPS TO UTILIZE CROSS- ORGANIZATIONAL EXPERTISE, GREATLY EXPANDING DONATION NETWORKS AND INCREASING PROCESSING CAPACITY, AND THEREFORE THE AVAILABILITY OF HUMAN DERMAL AND SPLIT-THICKNESS ALLOGRAFTS. MTF'S WOUND CARE DIVISION WAS ABLE TO EXPAND THE DISTRIBUTION OF ITS WOUND CARE PORTFOLIO TO MORE RECIPIENTS IN THE VA AND PUBLIC HOSPITALS IN 2020. MTF CONTINUED ITS CLINICAL STUDY PORTFOLIO, INCREASING ITS COMPENDIUM OF CLINICAL DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES. IN ADDITION TO RETAINING PERSONNEL AND CAREFULLY MONITORING AND ADAPTING TO SUPPLY CHAIN CHALLENGES, MTF WAS ALSO ABLE TO DONATE PERSONAL PROTECTIVE EQUIPMENT (PPE) TO LOCAL HEALTHCARE FACILITIES IN NEED DURING THE PANDEMIC. MTF CONTINUES INTO 2021 DEVELOPING NOVEL TISSUE FORMS AND PROCESSING METHODS TO SOLVE CLINICAL PROBLEMS. MTF IS FOCUSED ON HONORING THE DONATED GIFT OF HUMAN TISSUE, ENSURING QUALITY TISSUE FORMS, MAXIMIZING THE DONOR GIFT, AND WORKING WITH SURGEONS TO SAVE AND HEAL LIVES. ___________________________________________________________________________ IN 2019, MTF CONTINUED TO INCREASE TISSUE UTILIZATION AND PLACEMENT OF TISSUE FORMS IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS. IN THE ORTHOPEDICS MARKET, MTF LAUNCHED QUICKGRAFT, A PRE-SUTURED TENDON. THIS TECHNOLOGY ALLOWS MTF AND SURGEON PARTNERS TO HONOR THE DONATED GIFT BY INCREASING THE PREDICTABILITY OF SURGICAL PROCEDURES FOR THE PATIENT. MTF ALSO CONTINUED TO INCREASE ITS UTILITY OF THE MOPS OSTEOCHONDRAL PRESERVATION TECHNOLOGY. THIS TECHNOLOGY FURTHER HONORS THE GIFT BY EXTENDING THE STORAGE LIFE OF DONATED TISSUE. IN 2019 MTF BEGAN TO DISTRIBUTE CC+, A CORTICAL-CANCELLOUS BONE VOID FILLER. FURTHERMORE, MTF LAUNCHED A NEW CORTICAL FIBER BASED BONE VOID FILLER, FIBER FUSE, WHICH POSSESSES OSTEO-INDUCTIVE, OSTEO-CONDUCTIVE POTENTIAL AND EXCELLENT HANDLING PROPERTIES. IN PLASTIC AND RECONSTRUCTIVE SURGERY (PRS), MTF LAUNCHED FLEXHD PRE, AN INNOVATIVE TISSUE FORM, DESIGNED TO ALLOW SURGEONS GREATER OPTIONS FOR BREAST RECONSTRUCTION PROCEDURES FOLLOWING MASTECTOMY. THE MTF PRS DIVISION ALSO SAW AN INCREASED USE OF RENUVA, AN ADIPOSE MATRIX, FOR USES SUCH AS RECONSTRUCTION AND TREATMENT OF SMALL VOLUME DEFECTS WHERE HOST FAT HAS EITHER DECREASED OR BEEN DEGRADED OR LOST DUE TO TRAUMA OR DISEASE. MTF'S WOUND CARE DIVISION DEVELOPED AND LAUNCHED SOMAGEN, AN ACELLULAR DERMAL ALLOGRAFT AND LENEVA A SOFT TISSUE ADIPOSE MATRIX. MTF ALSO CONTINUED EXPANDING THE DISTRIBUTION OF ITS WOUND CARE PORTFOLIO TO MORE RECIPIENTS IN THE VA AND PUBLIC HOSPITALS THROUGHOUT THE YEAR. MTF CONTINUED TO EXPAND ITS CLINICAL STUDY PORTFOLIO, INCREASING ITS COMPENDIUM OF CLINICAL DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND BREAST RECONSTRUCTION. MTF CONTINUED ITS PROSPECTIVE RANDOMIZED CLINICAL TRIAL FOR FLEXHD PLIABLE ACELLULAR DERMAL MATRIX FOR USES SUCH AS BREAST RECONSTRUCTION FOLLOWING MASTECTOMY. IN THE WOUND CARE MARKET, CLINICAL STUDIES AND RESEARCH DATA HAVE PROVIDED THE INFORMATION FOR MTF TO ATTAIN COVERAGE FOR APPROXIMATELY 73% OF ALL COVERED AMERICAN LIVES IN 2019. MTF CONTINUED ITS SUPPORT OF THE AMERICAN SOCIETY OF PLASTIC SURGEONS (ASPS) AND THE PLASTIC SURGERY FOUNDATION (PSF) WHICH PROVIDES OPPORTUNITIES FOR SURGEONS TO PERFORM ALLOGRAFT BASED RESEARCH TO ADVANCE THE SCIENCE OF ALLOGRAFT USE IN PLASTIC/RECONSTRUCTIVE PROCEDURES. MTF ALSO REMAINS COMMITTED TO SUPPORTING BREAST RECONSTRUCTION AWARENESS (BRA) DAY EACH YEAR AND INCLUDES EDUCATION FOR BOTH PATIENTS AND SURGEONS ON THE OPTIONS AVAILABLE TODAY FOR WOMEN, HELPING TO ENSURE SURVIVORS' RIGHTS TO MAKE AN INFORMED DECISION. MTF ALSO CONTINUED ITS FINANCIAL PLEDGE OF (1M OVER FIVE YEARS) TO SUPPORT BIOLOGIC RESEARCH THROUGH THE PLASTIC SURGERY FOUNDATION (PSF). MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS. | Desc |
| Total Program Service Expenses | $393,280,876 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | false | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (true) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 339 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 1462 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | CA | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 11 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 10 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (true) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| Other Website | Yes (X) | OtherWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MICHAEL J KAWAS | PersonNm |
| Phone | 7326610202 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 125 MAY STREET | AddressLine1Txt |
| City | EDISON | CityNm |
| State Abbreviation | NJ | StateAbbreviationCd |
| ZIP | 088373264 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (29 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| WILLIAM W TOMFORD MD | |||||||||
| DIRECTOR | 4.00 | Yes (X) | $50,000 | $0 | $0 | ||||
| DONALD HACKBARTH MD | |||||||||
| DIRECTOR | 1.00 | Yes (X) | $20,000 | $0 | $0 | ||||
| DAN M SPENGLER MD | |||||||||
| DIRECTOR | 1.00 | Yes (X) | $22,500 | $0 | $0 | ||||
| JOSEPH A BUCKWALTER MD | |||||||||
| DIRECTOR | 1.00 | Yes (X) | $22,500 | $0 | $0 | ||||
| JOSEPH ZUCKERMAN MD | |||||||||
| DIRECTOR | 1.00 | Yes (X) | $14,000 | $0 | $0 | ||||
| ALLAN GROSS MD | |||||||||
| DIRECTOR | 1.00 | Yes (X) | $13,500 | $0 | $0 | ||||
| MARK BOLANDER MD | |||||||||
| DIRECTOR | 1.00 | Yes (X) | $17,500 | $0 | $0 | ||||
| DERYK JONES MD | |||||||||
| DIRECTOR | 1.00 | Yes (X) | $13,500 | $0 | $0 | ||||
| JOSEPH ROTH | |||||||||
| DIRECTOR | 1.00 | Yes (X) | $13,500 | $0 | $0 | ||||
| DAVID KULBER MD | |||||||||
| DIRECTOR | 1.00 | Yes (X) | $17,150 | $0 | $0 | ||||
| VICTOR FRANKEL MDPHD | |||||||||
| NON-VOTING D | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| GERALD FINERMAN MD | |||||||||
| NON-VOTING D | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| JAN FINN | |||||||||
| DIRECTOR | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| JOSEPH A YACCARINO | |||||||||
| PRESIDENT/CE | 60.00 | $779,998 | $0 | $199,290 | Yes (X) | ||||
| MICHAEL J KAWAS | |||||||||
| TREASURER/CF | 60.00 | $613,523 | $0 | $149,475 | Yes (X) | ||||
| JENNIFER BIRMINGHAM | |||||||||
| SECRETARY/GE | 60.00 | $428,275 | $0 | $119,959 | Yes (X) | ||||
| BRUCE W STROEVER | |||||||||
| PRES - ENDED | $378,469 | $0 | $0 | Yes (X) | |||||
| MARTHA ANDERSON | |||||||||
| EXEC VP DONO | 60.00 | $499,724 | $0 | $126,684 | Yes (X) | ||||
| THOMAS C SHAFFER | |||||||||
| EXEC VP SALE | 60.00 | $495,621 | $0 | $114,983 | Yes (X) | ||||
| MICHAEL OLECK | |||||||||
| EXEC VP OPS | 60.00 | $413,607 | $0 | $110,433 | Yes (X) | ||||
| MARC LONG | |||||||||
| EXEC R & D | 60.00 | $399,386 | $0 | $110,834 | Yes (X) | ||||
| BETH BRETT | |||||||||
| SURGICAL CON | 50.00 | $527,223 | $0 | $20,544 | Yes (X) | ||||
| BRANDON SPEARS | |||||||||
| SURGICAL CON | 50.00 | $338,448 | $0 | $34,432 | Yes (X) | ||||
| JODIE CRABIL | |||||||||
| SURGICAL CON | 50.00 | $323,628 | $0 | $33,178 | Yes (X) | ||||
| FLOYD VAUGHAN | |||||||||
| SURGICAL CON | 50.00 | $354,248 | $0 | $40,062 | Yes (X) | ||||
| ELYCE PINCUS | |||||||||
| WOUNDCARE CO | 50.00 | $385,548 | $0 | $33,403 | Yes (X) | ||||
| KIMBERLY A ROUNDS | |||||||||
| VP WOUND CAR | 50.00 | $361,709 | $0 | $80,099 | Yes (X) | ||||
| HEATHER BRENNAN | |||||||||
| VP FRANCHISE | 50.00 | $280,323 | $0 | $79,139 | Yes (X) | ||||
| BRADLEY BAILEY | |||||||||
| VP ORTHOPEDI | 50.00 | $262,851 | $0 | $73,331 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $7,046,731 | TotalReportableCompFromOrgAmt |
| Total Other Compensation | $1,325,846 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 266 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (true) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| ORTHOFIX SPINAL IMPLANTS | |||||
| 3451 PLANO PARKWAY | LEWISVILLE | TX | 75056 | TISSUE PROMO | $53,872,306 |
| DEPUY SYNTHES | |||||
| 1302 WRIGHTS LANE EAST | WEST CHESTER | PA | 19380 | TISSUE PROMO | $36,620,484 |
| CONMED LINVATEC | |||||
| 1250 TERMINUS DRIVE | LITHIA SPRINGS | GA | 30122 | TISSUE PROMO | $28,504,656 |
| DONOR NETWORK OF ARIZONA | |||||
| 201 W COOLIDGE ST | PHOENIX | AZ | 85013 | RECOVRY PARTNER | $7,066,753 |
| MIDWEST TRANSPLANT NETWORK | |||||
| 1900 WEST 47TH PLACE | WESTWOOD | KS | 66205 | RECOVRY PARTNER | $4,503,288 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 213 | CntrctRcvdGreaterThan100KCnt |
| All Other Contributions | $874,610 | AllOtherContributionsAmt |
| Total Contributions | $874,610 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| TISSUE PROCESSING & DISTRIB. | 621991 | $396,387,748 | $396,387,748 |
| DONOR SCREENING | 561421 | $8,620,712 | $8,620,712 |
| DISTRIBUTION RIGHTS PAYMENTS | 900099 | $7,023,027 | $7,023,027 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $412,031,487 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $240,659 | TotalRevenueColumnAmt |
| Exclusion | $240,659 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $312,863 | TotalRevenueColumnAmt |
| Exclusion | $312,863 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,831,957 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $550,113 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,281,844 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,281,844 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,281,844 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $1,654,896 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $10,316,877 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$8,661,981 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | -$8,661,981 | UnrelatedBusinessRevenueAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| DISTRIBUTION PARTNER REVENUE | 900099 | $3,277,856 | $3,277,856 |
| PARTNER REVENUE | 900099 | $948,625 | $948,625 |
| FREIGHT & DELIVERY REVENUE | 900099 | $835,327 | $835,327 |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $487,428 | TotalRevenueColumnAmt |
| Exclusion | $487,428 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $5,549,236 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $411,628,718 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $413,313,331 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | -$8,661,981 | UnrelatedBusinessRevenueAmt |
| Exclusion | $6,102,758 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $644,713 | TotalAmt |
| Program Services | $644,713 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,539,853 | TotalAmt |
| Program Services | $4,041,852 | ProgramServicesAmt |
| Management And General | $1,498,001 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $98,944,006 | TotalAmt |
| Program Services | $86,521,702 | ProgramServicesAmt |
| Management And General | $12,422,304 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,018,251 | TotalAmt |
| Program Services | $3,515,198 | ProgramServicesAmt |
| Management And General | $503,053 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,921,024 | TotalAmt |
| Program Services | $12,189,930 | ProgramServicesAmt |
| Management And General | $1,731,094 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,874,597 | TotalAmt |
| Program Services | $6,023,223 | ProgramServicesAmt |
| Management And General | $851,374 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,097,711 | TotalAmt |
| Program Services | $713,230 | ProgramServicesAmt |
| Management And General | $384,481 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $648,404 | TotalAmt |
| Management And General | $648,404 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $686,955 | TotalAmt |
| Program Services | $590,225 | ProgramServicesAmt |
| Management And General | $96,730 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,324,374 | TotalAmt |
| Program Services | $1,270,147 | ProgramServicesAmt |
| Management And General | $54,227 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $937,483 | TotalAmt |
| Program Services | $384,217 | ProgramServicesAmt |
| Management And General | $553,266 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,198,204 | TotalAmt |
| Program Services | $1,289,968 | ProgramServicesAmt |
| Management And General | $908,236 | ManagementAndGeneralAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,517,577 | TotalAmt |
| Program Services | $1,517,577 | ProgramServicesAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $10,950,089 | TotalAmt |
| Program Services | $9,846,713 | ProgramServicesAmt |
| Management And General | $1,103,376 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,343,979 | TotalAmt |
| Program Services | $1,204,519 | ProgramServicesAmt |
| Management And General | $139,460 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,180,211 | TotalAmt |
| Program Services | $1,616,658 | ProgramServicesAmt |
| Management And General | $563,553 | ManagementAndGeneralAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $442,588 | TotalAmt |
| Program Services | $442,588 | ProgramServicesAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,426,394 | TotalAmt |
| Program Services | $10,550,258 | ProgramServicesAmt |
| Management And General | $876,136 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,146,435 | TotalAmt |
| Program Services | $1,011,814 | ProgramServicesAmt |
| Management And General | $134,621 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt |
|---|---|---|
| STORAGE & DISTRIBUTION | $136,037,273 | $136,037,273 |
| PROCESSING COSTS | $95,307,219 | $95,307,219 |
| RECOVERY EXPENSES | $11,651,106 | $11,651,106 |
| RESEARCH AND DEVELOPMENT | $4,742,131 | $4,742,131 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,168,615 | TotalAmt |
| Program Services | $2,168,615 | ProgramServicesAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $415,749,192 | TotalAmt |
| Program Services | $393,280,876 | ProgramServicesAmt |
| Management And General | $22,468,316 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $65,566,358 | BOYAmt |
| EOY | $47,734,557 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $59,266,270 | BOYAmt |
| EOY | $56,678,223 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $97,877,352 | BOYAmt |
| EOY | $111,774,215 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,805,769 | BOYAmt |
| EOY | $2,531,347 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $124,304,946 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $93,973,651 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $27,694,316 | BOYAmt |
| EOY | $30,331,295 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $800,113 | BOYAmt |
| EOY | $250,000 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,525,000 | BOYAmt |
| EOY | $4,475,000 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,861,021 | BOYAmt |
| EOY | $11,940,701 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $269,396,199 | BOYAmt |
| EOY | $265,715,338 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $81,974,674 | BOYAmt |
| EOY | $76,714,734 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,073,420 | BOYAmt |
| EOY | $3,836,624 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $111,896,484 | BOYAmt |
| EOY | $105,623,457 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,447,069 | BOYAmt |
| EOY | $3,960,450 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,054,437 | BOYAmt |
| EOY | $9,344,341 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $206,446,084 | BOYAmt |
| EOY | $199,479,606 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $62,950,115 | BOYAmt |
| EOY | $66,235,732 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $62,950,115 | BOYAmt |
| EOY | $66,235,732 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $269,396,199 | BOYAmt |
| EOY | $265,715,338 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | -$4,120,474 | ReconcilationRevenueExpnssAmt |
| Other Changes In Net Assets | $7,406,091 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org509a2 | Yes (X) | PubliclySupportedOrg509a2Ind |
Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $386,750 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $796,083 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $860,500 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $890,250 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $874,610 | CurrentTaxYearAmt |
| Total | $3,808,193 | TotalAmt |
Gross Receipts Admissions GrossReceiptsAdmissionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $415,076,707 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $412,894,240 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $422,094,519 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $452,689,157 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $412,031,487 | CurrentTaxYearAmt |
| Total | $2,114,786,110 | TotalAmt |
Gross Receipts Non Unrlt Bus GrossReceiptsNonUnrltBusGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $6,235,464 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $7,848,069 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $7,186,368 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $6,886,071 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $5,549,236 | CurrentTaxYearAmt |
| Total | $33,705,208 | TotalAmt |
Total509 Total509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $421,698,921 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $421,538,392 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $430,141,387 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $460,465,478 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $418,455,333 | CurrentTaxYearAmt |
| Total | $2,152,299,511 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total509 | $2,152,299,511 | PublicSupportTotal509Amt |
Gross Investment Income509 GrossInvestmentIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,877,063 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $827,999 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,924,522 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,827,599 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $553,522 | CurrentTaxYearAmt |
| Total | $7,010,705 | TotalAmt |
Investment Income And UBTI InvestmentIncomeAndUBTIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,877,063 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $827,999 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,924,522 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,827,599 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $553,522 | CurrentTaxYearAmt |
| Total | $7,010,705 | TotalAmt |
Total Support Calendar Year TotalSupportCalendarYearGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $423,575,984 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $422,366,391 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $432,065,909 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $462,293,077 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $419,008,855 | CurrentTaxYearAmt |
| Total | $2,159,310,216 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support CY509 | 0.99680 | PublicSupportCY509Pct |
| Public Support PY509 | 0.99610 | PublicSupportPY509Pct |
| Investment Income CY | 0.00000 | InvestmentIncomeCYPct |
| Investment Income PY | 0.00000 | InvestmentIncomePYPct |
| Thirty Thr Pct Suprt Tests CY509 | Yes (X) | ThirtyThrPctSuprtTestsCY509Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | false | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | false | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | false | DirectContactLegislatorsInd |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | Yes (true) | OtherActivitiesInd |
| Other Activities | $35,000 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $35,000 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE C, PART II-B, LINE 1 | FormAndLineReferenceDesc |
| Explanation | MTF DOES NOT MAKE POLITICAL CAMPAIGN DONATIONS. THE ORGANIZATION INDIRECTLY PARTICIPATED IN LOBBYING ACTIVITIES THROUGH MEMBERSHIP FEES PAID TO THE AMERICAN ASSOCIATION OF TISSUE BANKS. | ExplanationTxt |
Schedule D IRS990ScheduleD
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $6,467,468 | OtherCostOrOtherBasisAmt |
| Book Value | $6,467,468 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $44,897,723 | OtherCostOrOtherBasisAmt |
| Depreciation | $40,032,100 | DepreciationAmt |
| Book Value | $4,865,623 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $44,255,043 | OtherCostOrOtherBasisAmt |
| Depreciation | $36,336,037 | DepreciationAmt |
| Book Value | $7,919,006 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $28,684,712 | OtherCostOrOtherBasisAmt |
| Depreciation | $17,605,514 | DepreciationAmt |
| Book Value | $11,079,198 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $30,331,295 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (4 entries)
| DescDesc | AmtAmt |
|---|---|
| OTHER | $6,330,806 |
| DUE TO AFFILIATES | $2,000,000 |
| PARTNER ADVANCE | $930,973 |
| CAPITAL LEASE | $82,562 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $9,344,341 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $412,303,879 | TotalRevEtcAuditedFinclStmtAmt |
| Other Revenue | $675,161 | OtherRevenueAmt |
| Revenue Not Reported | $675,161 | RevenueNotReportedAmt |
| Revenue Subtotal | $411,628,718 | RevenueSubtotalAmt |
| Total Revenue Per Form990 | $411,628,718 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $409,018,262 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $852,403 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $852,403 | ExpensesNotReportedAmt |
| Expenses Subtotal | $408,165,859 | ExpensesSubtotalAmt |
| Other Expenses Not Included | $7,583,333 | OtherExpensesNotIncludedAmt |
| Expenses Not Rpt Fincl Stmt | $7,583,333 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $415,749,192 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE D, PAGE 3, PART X | MTF FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS "MORE-LIKELY- THAN-NOT" TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. MTF HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX- EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT WAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. MTF HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2020. |
| SCHEDULE D, PAGE 4, PART XI, LINE 2D | UNREALIZED FOREIGN EXCHANGE 675,161 |
| SCHEDULE D, PAGE 4, PART XII, LINE 2D | ACCRUED GRANTS 852,403 |
| SCHEDULE D, PAGE 4, PART XII, LINE 4B | BOOK / TAX DEPRECIATION DIFFERENCE 7,583,333 |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | false | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)
| RegionRegionTxt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|
| EUROPE | 1 | PROGRAM SERVICES | TISSUE DISTRIBUTION | $2,667,775 |
| NORTH AMERICA | 1 | PROGRAM SERVICES | TISSUE DISTRIBUTION | $1,823,767 |
| EAST ASIA AND THE PACIFIC | 1 | PROGRAM SERVICES | TISSUE DISTRIBUTION | $6,430,686 |
| CENTRAL AMERICA & CARIBBEAN | 1 | PROGRAM SERVICES | TISSUE DISTRIBUTION | $82,683 |
| MIDDLE EAST & NORTH AFRICA | 1 | PROGRAM SERVICES | TISSUE DISTRIBUTION | $364,286 |
| SOUTH AMERICA | 1 | PROGRAM SERVICES | TISSUE DISTRIBUTION | $833,568 |
| SOUTH ASIA | 1 | PROGRAM SERVICES | TISSUE DISTRIBUTION | $19,373 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Employees | 7 | SubtotalEmployeesCnt |
| Total Employee | 7 | TotalEmployeeCnt |
| Subtotal Spent | $12,222,138 | SubtotalSpentAmt |
| Total Spent | $12,222,138 | TotalSpentAmt |
| Transfer To Foreign Corp | Yes (true) | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | false | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE F, PAGE 1, PART I, LINE 3 | FormAndLineReferenceDesc |
| Explanation | EUROPE 2,667,775 0 NORTH AMERICA 1,823,767 0 EAST ASIA AND THE PACIFIC 6,430,686 0 CENTRAL AMERICA & CARIBBEAN 82,683 0 MIDDLE EAST & NORTH AFRICA 364,286 0 SOUTH AMERICA 833,568 0 SOUTH ASIA 19,373 0 | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (51 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| CASE WESTERN RESERVE UNIVERSITY | |||||||
| 10900 EUCLID AVENUE | CLEVELAND | OH | 44106 | 341018992 | 501C3 | $8,500 | RESIDENT EDUCATION |
| CEDARS-SINAL MEDICAL CENTER | |||||||
| 8700 BEVERLY BLVD 65-WIL SUITE 11 | LOS ANGELES | CA | 900481804 | 951644600 | 501C3 | $10,000 | RESIDENT EDUCATION |
| CLEVELAND CLINIC FOUNDATION | |||||||
| 9500 EUCLID AVENUE A-41 | CLEVELAND | OH | 44195 | 340714585 | 501C3 | $8,500 | RESIDENT EDUCATION |
| COLUMBIA UNIVERSITY MEDICAL CENTER | |||||||
| 116 TH STREET AND BROADWAY | NEW YORK | NY | 10027 | 135598093 | 501C3 | $8,500 | RESIDENT EDUCATION |
| DUKE UNIVERSITY MEDICAL CENTER | |||||||
| 200 TRENT DRIVE ROOM 1581 | DURHAM | NC | 27710 | 560532129 | 501C3 | $7,000 | RESIDENT EDUCATION |
| LOUISIANA STATE UNIVERSITY | |||||||
| 204 THOMAS BOYD HALL | BATON ROUGE | LA | 708032901 | 726000848 | 501C3 | $7,000 | RESIDENT EDUCATION |
| MEDICAL UNIVERSITY OF SOUTH CAROLIN | |||||||
| 171 ASHLEY AVE CSB 708 | CHARELSTON | SC | 294252239 | 576000722 | 501C3 | $10,000 | RESIDENT EDUCATION |
| MEMORIAL SLOAN-KETTERING CANCER CEN | |||||||
| 1275 YORK AVENUE | NEW YORK | NY | 10021 | 131924236 | 501C3 | $8,500 | RESIDENT EDUCATION |
| NYU HOSPITAL FOR JOINT DISEASES | |||||||
| 301 EAST 17TH STREET | NEW YORK | NY | 10003 | 133971298 | 501C3 | $7,000 | RESIDENT EDUCATION |
| OCHSNER CLINIC FOUNDATION | |||||||
| 1201 S CLEARVIEW PARKWAY STE 104 | JEFFERSON | LA | 70121 | 720502505 | 501C3 | $10,000 | RESIDENT EDUCATION |
| OHIO STATE UNIVERSITY | |||||||
| 2050 KENNY ROAD SUITE 3100 | COLUMBUS | OH | 43221 | 501C3 | $8,500 | RESIDENT EDUCATION | |
| REGENTS OF THE UNIVERSITY OF CA LO | |||||||
| 10833 LECONTE AVENUE BOX 956902 | LOS ANGELES | CA | 90095 | 956006143 | 501C3 | $8,500 | RESIDENT EDUCATION |
| STANFORD UNIVERSITY | |||||||
| 2700 SAND HILL RD | MENO PARK | CA | 94025 | 941156365 | 501C3 | $8,500 | RESIDENT EDUCATION |
| BONE AND JOINT CLINIC OF HAWAII | |||||||
| 1329 LUSITANA STREET - SUITE 501 | HONOLULU | HI | 96813 | 990073524 | 501C3 | $7,000 | RESIDENT EDUCATION |
| TRIPLER ARMY MEDICAL CENTER | |||||||
| 1 JARRETT WHITE RD | HONOLULU | HI | 968595000 | 521317896 | 501C3 | $7,000 | RESIDENT EDUCATION |
| TULANE UNIVERSITY SCHOOL OF MEDICIN | |||||||
| 1430 TULANE AVENUE SL32 | NEW ORLEANS | LA | 70112 | 720423889 | 501C3 | $8,500 | RESIDENT EDUCATION |
| RUTGERS ROBERT WOOD JOHNSON MEDICAL | |||||||
| 51 FRENCH STREET | NEW BRUNSWICK | NJ | 08903 | 226001086 | 501C3 | $7,000 | RESIDENT EDUCATION |
| UNIVERSITY OF NORTH CAROLINA AT CHA | |||||||
| 3155 BIOINFORMATICS BLVD CB 7055 | CHAPEL HILL | NC | 27599 | 566001393 | 501C3 | $8,500 | RESIDENT EDUCATION |
| UNIVERSITY OF CALIFORNIA - DAVIS | |||||||
| 4860 Y STREET SUITE 3800 | SACRAMENTO | CA | 95817 | 946036494 | 501C3 | $7,000 | RESIDENT EDUCATION |
| UNIVERSITY OF SOUTHERN CALIFORNIA | |||||||
| 1520 SAN PABLO STREET SUITE 2000 | LOS ANGELES | CA | 90033 | 951642394 | 501C3 | $8,500 | RESIDENT EDUCATION |
| UNIVERSITY OF ARIZONA COLLEGE OF ME | |||||||
| 2800 E AJO WAY SUITE A | TUCSON | AZ | 85713 | 501C3 | $7,000 | RESIDENT EDUCATION | |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| MU320W | SAN FRANCISCO | CA | 94143 | 946036493 | 501C3 | $7,000 | RESIDENT EDUCATION |
| UNIVERSITY OF CONNECTICUT HEALTH CE | |||||||
| 263 FARMINGTON AVE MC 545 | FARMINGTON | CT | 060305456 | 521725543 | 501C3 | $7,000 | RESIDENT EDUCATION |
| UNIVERSITY OF MINNESOTA | |||||||
| 2450 RIVERSIDE AVENUE S R200 | MINNEAPOLIS | MN | 55454 | 416007513 | 501C3 | $7,000 | RESIDENT EDUCATION |
| UNIVERSITY OF NEBRASKA MEDICAL CENT | |||||||
| 668 SOUTH 41ST ORTHO 1080 | OMAHA | NE | 68198 | 470049123 | 501C3 | $7,000 | RESIDENT EDUCATION |
| MD ANDERSON CANCER CENTER | |||||||
| 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 746001118 | 501C3 | $8,500 | RESIDENT EDUCATION |
| UNIVERSITY OF TEXAS HEALTH SCIENCE | |||||||
| 6431 FANNIN ST RM 6144 | HOUSTON | TX | 77030 | 741761309 | 501C3 | $8,500 | RESIDENT EDUCATION |
| VANDERBILT UNIVERSITY MEDICAL CENTE | |||||||
| SOUTH TOWER - SUITE 4200 | NASHVILLE | TN | 37232 | 620476822 | 501C3 | $8,500 | RESIDENT EDUCATION |
| WAKE FOREST UNIVERSITY | |||||||
| MEDICAL CENTER BOULEVARD | WINSTONSALEM | NC | 27157 | 223849199 | 501C3 | $7,000 | RESIDENT EDUCATION |
| HENRY FORD HOSPITAL | |||||||
| 2799 WEST GRAND BOULEVARD | DETROIT | MI | 48202 | 381357020 | 501C3 | $8,500 | RESIDENT EDUCATION |
| MEDICAL COLLEGE OF WISCONSIN | |||||||
| PO BOX 26099 | MILWAUKEE | WI | 53226 | 390806261 | 501C3 | $7,000 | RESIDENT EDUCATION |
| UNIVERSITY OF MISSOURI ORTHOPAEDIC | |||||||
| MC213 DC05300 | COLUMBIA | MO | 65212 | 431212976 | 501C3 | $10,000 | RESIDENT EDUCATION |
| UNIVERSITY OF MISSISSIPPI FOUNDATIO | |||||||
| 2500 NORTH STATE STREET | JASON | MS | 39216 | 237310293 | 501C3 | $10,000 | RESIDENT EDUCATION |
| UNIVERSITY OF ARKANSAS FOR MEDICAL | |||||||
| 4301 W MARKHAM 531 | LITTLE ROCK | AR | 72205 | 716056774 | 501C3 | $10,000 | RESIDENT EDUCATION |
| RUTGERS BIOMEDICAL AND HEALTH SCIEN | |||||||
| 33 KNIGHTSBRIDGE ROAD | PISCATAWAY | NJ | 08854 | 462354111 | 501C3 | $7,000 | RESIDENT EDUCATION |
| FACULTY PHYSICIANS & SURGEONS OF L | |||||||
| 11175 CAMPUS ST ROOM 11120 | LOMA LINDA | CA | 92350 | 330672915 | 501C3 | $8,500 | RESIDENT EDUCATION |
| ALBANY MEDICAL COLLEGE | |||||||
| 1367 WASHINGTON AVENUE SUITE 200 | ALBANY | NY | 12206 | 141338307 | 501C3 | $8,500 | RESIDENT EDUCATION |
| SAN ANTONIO MILITARY MEDICAL CENTER | |||||||
| 110 WEST ROAD SUITE 227 | TOWSON | MD | 21204 | 473298617 | 501C3 | $8,500 | RESIDENT EDUCATION |
| MEDICAL COLLEGE OF GEORGIA | |||||||
| 720 ST SEBASTIAN WAY SUITE 150 | AUGUSTA | GA | 30901 | 580706796 | 501C3 | $8,500 | RESIDENT EDUCATION |
| ORTHOPAEDIC RESEARCH AND EDUCATION | |||||||
| 9400 WEST HIGGINS ROAD SUITE 215 | ROSEMONT | IL | 600184975 | 366009467 | 501C3 | $19,070 | SCIENTIFIC RESEARCH |
| UNIVERSITY OF CINCINNATI | |||||||
| PO BOX 210222 | CINCINNATI | OH | 452210222 | 316000989 | 501C3 | $50,000 | SCIENTIFIC RESEARCH |
| CLEMSON UNIVERSITY RESEARCH FOUNDAT | |||||||
| PO BOX 946 | CLEMSON | SC | 296330946 | 570750000 | 501C3 | $50,000 | SCIENTIFIC RESEARCH |
| NORTHWESTERN UNIVERSITY | |||||||
| 750 N LAKESHORE DR 7TH FL | CHICAGO | IL | 60611 | 362167817 | 501C3 | $50,000 | SCIENTIFIC RESEARCH |
| WAKE FOREST UNIVERSITY | |||||||
| MEDICAL CENTER BOULEVARD | WINSTONSALEM | NC | 27157 | 223849199 | 501C3 | $25,000 | SCIENTIFIC RESEARCH |
| NEW JERSEY INSTITUTE OF TECHNOLOGY | |||||||
| 323 MARTIN LUTHER KING BLVD | NEWARK | NJ | 071021982 | 226000910 | 501C3 | $25,000 | SCIENTIFIC RESEARCH |
| WAKE FOREST UNIVERSITY | |||||||
| MEDICAL CENTER BOULEVARD | WINSTONSALEM | NC | 27157 | 223849199 | 501C3 | $25,000 | SCIENTIFIC RESEARCH |
| CLEMSON UNIVERSITY RESEARCH FOUNDAT | |||||||
| PO BOX 946 | CLEMSON | SC | 296330946 | 570750000 | 501C3 | $25,000 | SCIENTIFIC RESEARCH |
| JOHNS HOPKINS UNIVERSITY | |||||||
| 3910 KESWICK RD | BALTIMORE | MD | 21211 | 520595110 | 501C3 | $25,000 | SCIENTIFIC RESEARCH |
| MUSCULOSKELETAL TUMOR SOCIETY | |||||||
| 9400 W HIGGINS ROAD SUITE 500 | ROSEMONT | IL | 60018 | 954480540 | 501C3 | $9,584 | SCIENTIFIC RESEARCH |
| RUTGERS BIOMEDICAL AND HEALTH SCIEN | |||||||
| 33 KNIGHTSBRIDGE ROAD | PISCATAWAY | NJ | 08854 | 462354111 | 501C3 | $6,629 | SCIENTIFIC RESEARCH |
| WEST VIRGINIA UNIVERSITY | |||||||
| 886 CHESTNUT RIDGE ROAD | MORGANTOWN | WV | 265069196 | 550665758 | 501C3 | $8,800 | SCIENTIFIC RESEARCH |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 51 | Total501c3OrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE I, PAGE 1, PART I, LINE 2 | FormAndLineReferenceDesc |
| Explanation | GRANTEE QUALIFICATIONS: GRANTS ARE AWARDED BY THE BOARD OF DIRECTORS IN THE FOLLOWING CATEGORIES: 1)ORTHOPEDIC RESEARCH GRANT: AWARDED THROUGH THE OREF (ORTHOPEDIC RESEARCH & EDUCATION FOUNDATION). THIS AWARD IS FOR RESEARCH RELATING TO ALLOGRAFT SCIENCE. THE PURPOSE IS TO FOSTER, PROMOTE, SUPPORT, AUGMENT, DEVELOP, AND ENCOURAGE INVESTIGATIVE KNOWLEDGE OF THE CAUSES, CURE, AND PREVENTION OF ORTHOPEDIC RELATED INJURIES AND CONDITIONS, AND TO ENCOURAGE RESEARCH IN THE FIELD OF ORTHOPEDIC SURGERY IN THE MUSCULOSKELETAL SYSTEM THROUGH THE AWARDING OF RESEARCH AND EDUCATIONAL GRANTS. ORGANIZATIONS FROM ANY ACCREDITED ORTHOPEDIC INSTITUTION MAY QUALIFY FOR THIS GRANT, 100,000 EACH. 2)PEER-REVIEW GRANTS: SCIENTIFIC RESEARCH GRANTS ARE AWARDED FOR THE CONTINUED RESEARCH TO DESIGN AND SUPPORT THE ADVANCEMENT OF ALLOGRAFT SCIENCE TO BOTH MEMBER AND NON-MEMBER ACADEMIC INSTITUTIONS. THERE ARE TWO LEVELS OF THIS TYPE OF GRANT: A)JUNIOR INVESTIGATOR AWARDS FOR NEW PRINCIPAL RESEARCHERS ARE AVAILABLE FOR UP TO 100,000 EACH FOR ONE YEAR, NON-RENEWABLE AND B)ESTABLISHED INVESTIGATOR AWARDS FOR EXPERIENCED PRINCIPAL RESEARCHERS ARE AVAILABLE FOR UP TO 100,000 EACH PER YEAR FOR UP TO THREE YEARS. IN ADDITION, PEER REVIEW GRANTS ARE SUBJECT TO REVIEW AND EVALUATED FOR QUALITY BY INDEPENDENT GRANT REVIEWERS. 3)ACADEMIC CAREER DEVELOPMENT: THIS AWARD IS INTENDED TO FOSTER THE DEVELOPMENT OF OUTSTANDING ORTHOPEDIC CLINICIANS AND ENABLE THEM TO EXPAND THEIR POTENTIAL TO MAKE SIGNIFICANT RESEARCH CONTRIBUTIONS TO THE FIELD OF ORTHOPEDICS. ONLY APPLICANTS FROM FOUNDATION MEMBER INSTITUTIONS ARE ELIGIBLE. AWARDS ARE FOR UP TO 100,000 EACH PER YEAR FOR UP TO THREE YEARS. 4)HERNDON RESIDENCY AWARD: THE AWARD IS AWARDED FOR ORTHOPEDIC RESIDENT RESEARCH PROJECTS THROUGH THE OREF (ORTHOPEDIC RESEARCH & EDUCATION FOUNDATION). ORGANIZATIONS FROM ANY ACCREDITED INSTITUTION MAY QUALIFY FOR THIS GRANT. TWO AWARDS AT 20,000 EACH. 5)GRANT REVIEWER STIPENDS: GRANT REVIEWER STIPENDS ARE PAID TO INDEPENDENT REVIEWERS FOR REVIEWING AND EVALUATING FOR QUALITY THE PEER REVIEW GRANT PROPOSALS. 6)MTF BOD DIRECTED RESEARCH: PROJECTS DIRECTLY DISCUSSED, AUTHORIZED AND INITIATED BY THE BOARD OF DIRECTORS. ORGANIZATIONS FROM ANY ACCREDITED INSTITUTION MAY QUALIFY FOR THIS TYPE OF GRANT. INDIVIDUAL AMOUNTS VARY BASED ON THE BUDGET NECESSARY TO CONCLUDE THE RESEARCH INITIATIVE. 7) PLASTIC AND RECONSTRUCTIVE SURGERY RESEARCH GRANT: AWARDED THROUGH THE PSF (THE PLASTIC SURGERY FOUNDATION). THIS AWARD IS FOR RESEARCH RELATING TO BIOLOGIC RECONSTRUCTION IN PLASTIC AND RECONSTRUCTIVE SURGERY AND WOUND CARE. THE PURPOSE IS TO FOSTER, PROMOTE, SUPPORT, AUGMENT, DEVELOP, AND ENCOURAGE INVESTIGATIVE KNOWLEDGE OF THE CAUSES, CURE, AND PREVENTION OF INJURIES AND CONDITIONS IN THE FIELDS OF PLASTIC AND RECONSTRUCTIVE SURGERY AND WOUND CARE, AND TO ENCOURAGE RESEARCH IN THE FIELDS PLASTIC AND RECONSTRUCTIVE SURGERY AND WOUND CARE THROUGH THE AWARDING OF RESEARCH AND EDUCATIONAL GRANTS. ORGANIZATIONS FROM ANY ACCREDITED INSTITUTION MAY QUALIFY FOR THIS GRANT. 100,000 (MAXIMUM) EACH. ALL RECIPIENTS OF MTF GRANT AWARDS WILL RECEIVE THEIR SUPPORT MADE IN INSTALLMENT PAYMENTS DURING THE GRANT PERIOD WHICH MAY BE AS LONG AS SEVERAL YEARS. THE FINAL INSTALLMENT PAYMENT WILL BE MADE UPON RECEIPT OF A FINAL RESEARCH REPORT. A DETAILED BUDGET SHOWING USE OF ALL FUNDS AWARDED IS ALSO REQUIRED AS PART OF THE REPORT MADE TO MTF PRIOR TO THE RELEASE OF THE FINAL INSTALLMENT. TWO 6-MONTH, NO COST EXTENSIONS OF THE GRANT MAY BE REQUESTED FORMALLY. IF THE GRANT IS NOT COMPLETED BY THE AGREED COMPLETION DATE, THE GRANTEE WILL LOSE THE REMAINING INSTALLMENT OF THE GRANTED FUNDS. UNUSUAL CIRCUMSTANCES WILL BE CONSIDERED. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (16 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt |
|---|---|---|---|---|---|---|
| JOSEPH A YACCARINO | ||||||
| PRESIDENT/CEO | $559,607 | $195,315 | $25,076 | $172,047 | $29,725 | $979,288 |
| MICHAEL J KAWAS | ||||||
| TREASURER/CFO | $483,784 | $124,516 | $5,223 | $128,272 | $24,248 | $762,998 |
| JENNIFER BIRMINGHAM | ||||||
| SECRETARY/GEN COUNSL | $345,312 | $81,445 | $1,518 | $92,666 | $30,338 | $548,234 |
| BRUCE W STROEVER | ||||||
| PRES - ENDED 6/30/18 | $378,469 | $378,469 | ||||
| MARTHA ANDERSON | ||||||
| EXEC VP DONOR SRVS | $390,868 | $99,634 | $9,222 | $107,134 | $22,595 | $626,408 |
| THOMAS C SHAFFER | ||||||
| EXEC VP SALES & MKTG | $393,201 | $99,582 | $2,838 | $102,895 | $15,133 | $610,604 |
| MICHAEL OLECK | ||||||
| EXEC VP OPS | $322,140 | $87,111 | $4,356 | $88,605 | $24,810 | $524,040 |
| MARC LONG | ||||||
| EXEC R & D | $320,258 | $77,610 | $1,518 | $83,085 | $30,618 | $510,220 |
| BETH BRETT | ||||||
| SURGICAL CONSULTANT | $86,711 | $440,331 | $181 | $18,581 | $2,671 | $547,767 |
| BRANDON SPEARS | ||||||
| SURGICAL CONSULTANT | $67,525 | $270,803 | $120 | $7,708 | $27,944 | $372,880 |
| JODIE CRABIL | ||||||
| SURGICAL CONSULTANT | $70,069 | $253,450 | $109 | $8,635 | $25,203 | $356,806 |
| FLOYD VAUGHAN | ||||||
| SURGICAL CONSULTANT | $80,387 | $273,283 | $578 | $14,519 | $26,251 | $394,310 |
| ELYCE PINCUS | ||||||
| WOUNDCARE CONSULTANT | $93,710 | $291,216 | $622 | $13,014 | $21,275 | $418,951 |
| KIMBERLY A ROUNDS | ||||||
| VP WOUND CARE | $299,255 | $60,936 | $1,518 | $80,099 | $2,305 | $441,808 |
| HEATHER BRENNAN | ||||||
| VP FRANCHISE | $279,349 | $974 | $52,596 | $28,780 | $359,462 | |
| BRADLEY BAILEY | ||||||
| VP ORTHOPEDICS | $261,471 | $1,380 | $48,788 | $26,700 | $336,182 | |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE J, PAGE 1, PART I, LINE 4 | BRUCE W. STROEVER 378,469 0 0 |
| SCHEDULE J, PAGE 1, PART I, LINE 7 | NON-FIXED MONETARY AMOUNTS ARE CONTINGENT UPON DISCRETIONARY FACTORS INCLUDING THE PROGRAM SERVICE ACCOMPLISHMENTS OF THE FOUNDATION AND THE CURRENT MARKET CONDITIONS. THE COMPENSATION COMMITTEE OF THE FOUNDATION'S BOARD OF DIRECTORS HAS THE PRIMARY RESPONSIBILITY OF REVIEWING AND APPROVING THE NON-FIXED COMPENSATION OF THE FOUNDATION'S CEO AND OTHER NAMED EXECUTIVE OFFICERS. |
Schedule M IRS990ScheduleM
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | TISSUE FORMS | Desc |
| Contribution | 13705 | ContributionCnt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | false | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE M, PAGE 2, PART II | FormAndLineReferenceDesc |
| Explanation | PART I, LINE 33 - EXPLANATION FOR NOT REPORTING REVENUE FORM 990 SCHEDULE M - ALLOGRAFT TISSUE DONATION FORM 990 THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF- OR THE "FOUNDATION") RECOVERS, PROCESSES AND/OR DISTRIBUTES DONATED HUMAN TISSUES FOR TRANSPLANT, EDUCATION AND RESEARCH PURPOSES. THESE TISSUES INCLUDE MUSCULOSKELETAL TISSUES (E.G., BONE, TENDON, LIGAMENT, AND CARTILAGE) AND DERMAL TISSUES, BIRTH TISSUE, AND NON-TRANSPLANTABLE ORGANS (E.G., LIVERS, HEARTS, LUNGS; WHICH ARE USED SOLELY FOR RESEARCH PURPOSES). ALL ORGANS AND TISSUES ARE DONATED ACCORDING TO ESTABLISHED STATE AND FEDERAL LAWS AND REGULATIONS, INCLUDING THE NATIONAL ORGAN TRANSPLANT ACT AND UNIFORM ANATOMICAL GIFT ACT. NO REMUNERATION IS PROVIDED TO THE DONOR OR THEIR FAMILY FOR THE DONATION. TISSUES ARE RECOVERED EITHER DIRECTLY BY THE FOUNDATION OR BY AFFILIATED ORGANIZATIONS (E.G., ORGAN PROCUREMENT ORGANIZATIONS, EYE AND TISSUE BANKS) THAT THE FOUNDATION HAS FORMAL WRITTEN AGREEMENTS. COSTS ASSOCIATED WITH THE RECOVERY PROCESS ARE REIMBURSED BY THE FOUNDATION TO THE AFFILIATED ORGANIZATIONS. NO VALUE IS ASSIGNED TO THE DONATED TISSUES OR ORGANS. THE COSTS ASSOCIATED WITH RECOVERY, PROCESSING AND DISTRIBUTION ARE CAPITALIZED WHEN INCURRED. THIS VALUE IS THE BASIS OF INVENTORY AVAILABLE FOR TRANSPLANTATION AND/OR RESEARCH. THE FOUNDATION THEN CHARGES A SERVICE FEE FOR THE COSTS ASSOCIATED WITH THE RECOVERY, PREPARATION, STORAGE, AND DISTRIBUTION OF THE TISSUES. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (13 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990 - ORGANIZATION'S MISSION | MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF- OR THE "FOUNDATION") IS DEDICATED TO PROVIDING QUALITY ALLOGRAFT TISSUE FOR TRANSPLANTATION THROUGH A COMMITMENT TO EXCELLENCE IN EDUCATION, RESEARCH, RECOVERY, AND CARE FOR RECIPIENTS, DONORS AND THEIR FAMILIES. MTF CONTINUES TO PROMOTE THE HEALTH AND WELFARE OF THE GENERAL PUBLIC BY (1) MAXIMIZING THE AVAILABILITY OF HIGH QUALITY HUMAN TISSUE INCLUDING BONE, DERMAL AND BIRTH TISSUE; 2) SUPPORTING MEDICAL, SCIENTIFIC AND OTHER EDUCATIONAL RESEARCH WITH RESPECT TO TISSUE DONATION, RECOVERY AND TRANSPLANTATION; AND(3) EDUCATING THE GENERAL PUBLIC WITH RESPECT TO THE IMPORTANCE AND BENEFITS OF TISSUE DONATION AND TRANSPLANTATION. THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. WAS INCORPORATED ON JANUARY 30, 1987, AS A DISTRICT OF COLUMBIA NON- PROFIT MEMBERSHIP ORGANIZATION AND IS A 501(C)(3)ORGANIZATION. THERE IS A CRITICAL NEED FOR MUSCULOSKELETAL, CARDIOVASCULAR, SKIN, BIRTH AND OCULAR TISSUE FOR TRANSPLANTATION. IN ORDER TO ACCOMPLISH MTF'S MISSION AND THESE ACTIVITIES, THE FOUNDATION MAINTAINS A DONOR RECOVERY NETWORK, SUPPORTS DONOR AWARENESS PROGRAMS FOR THE PUBLIC, DONATES BONE AND OTHER TISSUE FOR RESEARCH, PROVIDES RESEARCH GRANTS, AND OTHERWISE SUPPORTS BONE, SKIN, WOUND CARE AND CARDIOVASCULAR TISSUE TRANSPLANTATION, RESEARCH AND EDUCATIONAL PROGRAMS. THE FOUNDATION'S MEMBERSHIP IS COMPRISED OF 501(C)(3) NON-PROFIT ORGANIZATIONS. THE MEMBERSHIP CONSISTS OF FORTY-SEVEN ACADEMIC MEMBERS (ORTHOPEDIC TEACHING INSTITUTIONS), THIRTY-ONE RECOVERY ORGANIZATIONS (ORGAN, EYE AND TISSUE PROCUREMENT ORGANIZATIONS) THROUGHOUT THE UNITED STATES. BIOCON, INC., A NON-PROFIT 501(C)(3) ORGANIZATION, SERVES AS THE SOLE CORPORATE MEMBER OF THE FOUNDATION. THE FOUNDATION MAINTAINS A NATIONWIDE DONOR RECOVERY NETWORK THAT IS BASED ON ITS AFFILIATION WITH ITS RECOVERY AND REFERRING MEMBERS. THIS NATIONAL NETWORK ALLOWS THE PUBLIC TO QUICKLY ACCESS NEEDED ALLOGRAFT TISSUE. BONE AND OTHER ALLOGRAFT TISSUE RECOVERED THROUGH THIS NETWORK IS SUBJECT TO STANDARDIZED SCREENING CRITERIA FOR DONATION ESTABLISHED BY THE FOUNDATION'S MEDICAL BOARD OF TRUSTEES AND DONATION BOARD OF TRUSTEES (DESCRIBED BELOW). THE FOUNDATION ALSO MAINTAINS A QUALITY ASSURANCE PROGRAM WITH RESPECT TO ALLOGRAFT TISSUES RECOVERED THROUGH THE NETWORK. THIS QUALITY PROGRAM IS BASED ON THE POLICIES ADOPTED BY THE AMERICAN ASSOCIATION OF TISSUE BANKS AND THE REGULATIONS PUBLISHED BY THE FOOD & DRUG ADMINISTRATION AND OTHER REGULATORY AGENCIES OUTSIDE THE U.S WHERE THE FOUNDATION DISTRIBUTES TISSUE. THE FOUNDATION PROVIDES RECOVERY ORGANIZATION MEMBERS AND THE GENERAL COMMUNITY THEY SERVE WITH FUNDING FOR HOSPITAL DEVELOPMENT AND DONOR AWARENESS SERVICES. THESE SERVICES ALSO INCLUDE PROVIDING TRAINING TO RECOVERY ORGANIZATION MEMBERS, EDUCATIONAL SYMPOSIUMS TO BOTH RECOVERY ORGANIZATION MEMBERS AND HOSPITAL STAFF, AND EDUCATIONAL MATERIALS FOR USE IN SEMINARS TO HOSPITAL PROFESSIONALS AND THE GENERAL PUBLIC. AS INDICATED IN ARTICLE III OF THE FOUNDATION'S BYLAWS, A MEMBER OF THE FOUNDATION CAN BE AN ACADEMIC MEDICAL INSTITUTION WITH AN ACCREDITED RESIDENCY TRAINING PROGRAM; A FEDERALLY CHARTERED OPO; OR AN EYE/TISSUE BANK. ALL MEMBERS AGREE TO SUPPORT THE FOUNDATION'S MISSION EITHER THROUGH A SERVICES AND SUPPLY AGREEMENT OR SERVICES AND RECOVERY AGREEMENT. SOME MEMBERS ARE ELIGIBLE FOR RESEARCH FUNDING (SEE SCHEDULE I, PT. IV FOR GRANT PROGRAM OVERVIEW) FROM THE FOUNDATION UPON RECOMMENDATION AND/OR APPROVAL OF EITHER THE BOARD OF DIRECTORS OR THE MEDICAL BOARD OF TRUSTEES. ALTHOUGH ALL OF THE FOUNDATION'S MEMBERS ARE NON-PROFIT 501(C)(3) ORGANIZATIONS, THE FOUNDATION MAKES ITS TRANSPLANTATION TISSUE NETWORK AND PROGRAMS AVAILABLE TO ANY PERSON OR ORGANIZATION (TYPICALLY THROUGH THEIR HOSPITALS AND PHYSICIANS)IN NEED OF ALLOGRAFT TISSUE. THE FOUNDATION FUNDS ALL COSTS ASSOCIATED WITH THE RECOVERY OF DONOR TISSUES. IT SUPPORTS THESE COSTS WITH FEES INTENDED TO COVER ITS EXPENSES (INCLUDING FUNDING FOR RESEARCH) FROM THE USER OF THE TISSUE. THE FOUNDATION WILL MAKE SUCH TISSUE AVAILABLE AT A REDUCED FEE OR NO CHARGE FOR VARIOUS CAUSES INCLUDING TRANSPLANTATION AND FOR PURPOSES OF RESEARCH BY 501(C)(3) ORGANIZATIONS. ALL FUNDS REALIZED BY THE FOUNDATION ARE USED TO COVER THE COSTS OF ITS PROGRAM ACTIVITIES (INCLUDING OVERHEAD)WITH ANY SURPLUS APPLIED TOWARDS SUBSIDIZING THE COSTS OF THOSE IN NEED OF TISSUE WHO ARE UNABLE TO AFFORD IT, TO FUND EDUCATION AND RESEARCH, TO MAINTAIN THE APPROPRIATE INFRASTRUCTURE AND/OR TO BUILD UP RESERVES NEEDED TO MAINTAIN AND EXPAND THE FOUNDATION'S PROGRAMS. WHILE THE FOUNDATION'S ACTIVITIES ARE MONITORED BY ITS MEMBERS, THE FOUNDATION HAS AN ELEVEN PERSON BOARD OF DIRECTORS AND TWO NON-VOTING EMERITUS MEMBERS. THIS BOARD IS COMPRISED PRIMARILY OF WORLD RENOWN EXPERTS FROM THE NON-PROFIT HEALTHCARE COMMUNITY HAVING VARIOUS SCIENTIFIC, TRANSPLANT, AND MEDICAL SPECIALTIES. THE BOARD OF DIRECTORS HAS ULTIMATE RESPONSIBILITY TO MANAGE THE FOUNDATION. OF THE BOARD'S 11 VOTING MEMBERS, THERE ARE TWO MEMBERS EACH FROM THE MEDICAL BOARD AND THE DONATION BOARD OF TRUSTEES. SERVING IN TANDEM WITH OTHER BOARD OF DIRECTORS, THE FOUNDATION HAS A MEDICAL BOARD OF TRUSTEES (THE "MEDICAL BOARD") AND A DONATION BOARD OF TRUSTEES ("DONATION BOARD"). THE MEDICAL BOARD IS COMPRISED OF RESPECTIVE PHYSICIANS FROM ORTHOPEDIC AND PLASTIC SURGERY DEPARTMENTS OF THE ACADEMIC INSTITUTION MEMBERS OF THE FOUNDATION, PLUS ADDITIONAL PERSONS WHO HAVE SPECIFIC EXPERTISE PERTAINING TO TRANSPLANTATION ETHICS AND RESEARCH ACTIVITIES WITHIN THE INDUSTRY. WHILE THE SPECIFIC POWERS AND RESPONSIBILITIES OF THE MEDICAL BOARD ARE DETAILED IN ARTICLE IV, SECTION 2 OF THE FOUNDATION'S BYLAWS, IN GENERAL IT PROVIDES THAT THE MEDICAL BOARD SHALL ADVISE THE FOUNDATION WITH RESPECT TO OPTIMIZING THE DISTRIBUTION OF RESEARCH GRANTS, THE CHOICE OF AREAS MERITING RESEARCH FUNDING, AND ESTABLISHING THE STANDARD POLICIES AND PROTOCOLS RELATING TO THE SCREENING, RECOVERY, TRANSPORT, TESTING, PROCESSING, STORAGE AND DISTRIBUTION OF TRANSPLANTABLE BONE AND TISSUE. THE DONATION BOARD IS COMPRISED OF INDIVIDUALS KNOWLEDGEABLE IN THE FIELD OF TISSUE DONATION AND RECOVERY AND ARE LEADERS OF THE FOUNDATION'S RECOVERY ORGANIZATION MEMBERSHIP. WHILE THE SPECIFIC POWERS AND RESPONSIBILITIES OF THE DONATION BOARD ARE DETAILED IN ARTICLE VI, SECTION 2 OF THE FOUNDATION'S BYLAWS, IN GENERAL THE DONATION BOARD PROVIDES THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT OF THE FOUNDATION WITH RECOMMENDATIONS WITH REGARD TO TISSUE DONATION PRACTICES SUCH AS SCREENING, RECOVERY, AND TESTING CRITERIA. THE FOUNDATION SUPPORTS EDUCATIONAL, SCIENTIFIC AND RESEARCH PROJECTS BY DISTRIBUTING FUNDS AND MAKING AVAILABLE, AT NO CHARGE, DONATED TISSUE FOR RESEARCH. THE FOUNDATION FUNDS MANY TYPES OF PROJECTS RELATED TO ADVANCING TRANSPLANT SCIENCE. ACCORDINGLY, GRANTS ARE PROVIDED FOR PROJECTS IN TISSUE DONATION AND APPLICATION. IN SUM, ALL OF THE ACTIVITIES OF THE FOUNDATION HAVE BEEN AND WILL BE DIRECTED AT MEETING THE NEEDS OF THE GENERAL PUBLIC FOR ALLOGRAFT TISSUE AND/OR IMPROVING THE MANNER IN WHICH TRANSPLANT TISSUE IS MADE AVAILABLE TO THE GENERAL PUBLIC. ADDITIONALLY, THE FOUNDATION SUPPORTS RESEARCH TO ADVANCE THE SCIENCE OF MUSCULOSKELETAL AND OTHER TISSUE APPLICATIONS. THE FOUNDATION OFFERS EDUCATIONAL SERVICE TO SURGEONS AND NURSES BY WAY OF CONTINUING MEDICAL EDUCATION (CME) AND CONTACT HOUR PROGRAMS. IN ADDITION, THE FOUNDATION PROVIDES EDUCATION THROUGH A SPEAKER PROGRAM IN CONJUNCTION WITH ORTHOPEDIC TEACHING HOSPITALS ACROSS THE UNITED STATES. SURGEONS UTILIZE THE FOUNDATION'S ALLOGRAFT FORMS DURING PROCEDURAL TRAINING OR CADAVERIC SPECIMENS DURING CME COURSES. FINALLY, THE FOUNDATION OFFERS GRANTS TO ITS RECOVERY PARTNERS TO EDUCATE THE PUBLIC AND HEALTHCARE PROFESSIONAL INVOLVED IN THE DONATION PROCESS. |
| FORM 990, PAGE 1, PART I, LINE 6 | COMPASSIONATE CARE FOR DONOR FAMILIES IS AT THE HEART OF OUR MISSION AT MTF THE DONOR FAMILY SUPPORT SERVICES VOLUNTEERS NEVER FORGETS THE MAGNITUDE OF THE GIFT OUR DONORS AND THEIR FAMILIES MAKE. WE'VE SET THIS SITE UP JUST FOR YOU, A PLACE YOU CAN COME TO LEARN ABOUT TISSUE DONATION, FIND HELPFUL RESOURCES AND MORE. WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS-COMMUNITY/DONORS-FAMILIES OUR VOLUNTEERS ARE THERE TO HELP YOU COPE WITH YOUR LOSS, WHILE APPRECIATING THE INCREDIBLE GIFT YOUR LOVED ONE HAS MADE TO OTHERS INCLUDING PERIODIC PERSONAL PHONE CALLS, REMEMBRANCES INCLUDING SYMPATHY CARDS, FREE INFORMATIVE PACKET WITH BEREAVEMENT SUPPORT LITERATURE, SUPPORT GROUP INFORMATION AND MORE. MTF VOLUNTEER GROUPS COMPRISED OF DONOR FAMILY MEMBERS AND BIRTH TISSUE DONORS WHO SHARE THEIR STORIES AND ENCOURAGE OTHERS TO CONSIDER DONATION. MANY FAMILIES HAVE FOUND THAT BEING INVOLVED WITH OTHER DONOR FAMILIES HAS A PROFOUND EFFECT ON THEIR LIVES AND APPRECIATE THE OPPORTUNITY TO SHARE THE STORY OF THEIR LOVED ONES. TISSUE RECIPIENTS HAVE INSPIRATIONAL STORIES OF HOW A TRANSPLANT TRANSFORMED THEIR LIVES. OUR VOLUNTEERS ARE LOCATED THROUGHOUT THE COUNTRY. WE CAN PROVIDE YOU WITH INFORMATION ON HOW YOU CAN GET INVOLVED AND VOLUNTEER BY CONTACTING VOLUNTEERS@MTF.ORG. THE LINKING LIVES PROGRAM IS A VOLUNTARY PROGRAM THAT GIVES TISSUE RECIPIENTS THE OPPORTUNITY TO WRITE A LETTER OF THANKS TO THEIR DONOR FAMILY. RECIPIENTS ARE ENCOURAGED TO WRITE A LETTER WHICH MTF WILL FORWARD TO THE AGENCY THAT COORDINATED THE TISSUE RECOVERY. WE PROVIDE TISSUE RECIPIENTS WITH GUIDELINES FOR WRITING TO THEIR DONOR FAMILY. THE RECOVERY AGENCY SENDS THE LETTER TO THE DONOR FAMILY. DONOR FAMILIES MAY NOT HEAR FROM THEIR TISSUE RECIPIENTS AS MANY PATIENTS ARE UNAWARE THAT THEY CAN WRITE TO THEIR DONOR FAMILIES. HOWEVER, THOSE WHO DO RECEIVE A LETTER FROM A GRATEFUL TISSUE RECIPIENT HAVE SHARED HOW IMPORTANT THOSE LETTERS CAN BE. |
| FORM 990, PAGE 2, PART III, LINE 4A | MTF PROVIDES ALLOGRAFT TISSUES TO THE MEDICAL COMMUNITY. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 150,000 DONORS. IN 2020, MTF RECOVERED TISSUE FROM OVER 5,500 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 6,300 DONORS FOR USE IN BURN, GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 1,100 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 683 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED APPROXIMATELY 400,000 UNITS OF ALLOGRAFT TISSUE DURING 2020. IN ADDITION TO THE FURTHERANCE OF THE MISSION DRIVEN RESULTS IN 2019 (HIGHLIGHTED BELOW) AND GIVEN THE CHALLENGES FACED IN 2020, MTF CONTINUES TO DEVELOP INNOVATIVE TISSUE FORMS, FOCUSED ON SOLVING REAL-WORLD, CLINICAL PROBLEMS. MTF HAS ALSO CONTINUED ITS EFFORTS TO PROVIDE SPECIAL RESEARCH TISSUE FOR RESEARCH PERFORMED BY MEMBERS OF THE ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE, AN ORGANIZATION DEDICATED TO DEVELOPING MEDICAL THERAPIES FOR WOUNDED SOLDIERS. MTF CONTINUED TO MAKE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS. IN THE ORTHOPEDICS FRANCHISE, MTF DEVELOPED NEW PARTNERSHIPS, FURTHER ENHANCING ITS OUTREACH, DISTRIBUTION NETWORK, AND ABILITY TO BRING DONATED ALLOGRAFT TISSUES TO PATIENT RECIPIENTS. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY FRANCHISE, MTF DEVELOPED STRATEGIC INTER-INDUSTRY PARTNERSHIPS TO UTILIZE CROSS- ORGANIZATIONAL EXPERTISE, GREATLY EXPANDING DONATION NETWORKS AND INCREASING PROCESSING CAPACITY, AND THEREFORE THE AVAILABILITY OF HUMAN DERMAL AND SPLIT-THICKNESS ALLOGRAFTS. MTF'S WOUND CARE DIVISION WAS ABLE TO EXPAND THE DISTRIBUTION OF ITS WOUND CARE PORTFOLIO TO MORE RECIPIENTS IN THE VA AND PUBLIC HOSPITALS IN 2020. MTF CONTINUED ITS CLINICAL STUDY PORTFOLIO, INCREASING ITS COMPENDIUM OF CLINICAL DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES. IN ADDITION TO RETAINING PERSONNEL AND CAREFULLY MONITORING AND ADAPTING TO SUPPLY CHAIN CHALLENGES, MTF WAS ALSO ABLE TO DONATE PERSONAL PROTECTIVE EQUIPMENT (PPE) TO LOCAL HEALTHCARE FACILITIES IN NEED DURING THE PANDEMIC. MTF CONTINUES INTO 2021 DEVELOPING NOVEL TISSUE FORMS AND PROCESSING METHODS TO SOLVE CLINICAL PROBLEMS. MTF IS FOCUSED ON HONORING THE DONATED GIFT OF HUMAN TISSUE, ENSURING QUALITY TISSUE FORMS, MAXIMIZING THE DONOR GIFT, AND WORKING WITH SURGEONS TO SAVE AND HEAL LIVES. ___________________________________________________________________________ IN 2019, MTF CONTINUED TO INCREASE TISSUE UTILIZATION AND PLACEMENT OF TISSUE FORMS IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS. IN THE ORTHOPEDICS MARKET, MTF LAUNCHED QUICKGRAFT, A PRE-SUTURED TENDON. THIS TECHNOLOGY ALLOWS MTF AND SURGEON PARTNERS TO HONOR THE DONATED GIFT BY INCREASING THE PREDICTABILITY OF SURGICAL PROCEDURES FOR THE PATIENT. MTF ALSO CONTINUED TO INCREASE ITS UTILITY OF THE MOPS OSTEOCHONDRAL PRESERVATION TECHNOLOGY. THIS TECHNOLOGY FURTHER HONORS THE GIFT BY EXTENDING THE STORAGE LIFE OF DONATED TISSUE. IN 2019 MTF BEGAN TO DISTRIBUTE CC+, A CORTICAL-CANCELLOUS BONE VOID FILLER. FURTHERMORE, MTF LAUNCHED A NEW CORTICAL FIBER BASED BONE VOID FILLER, FIBER FUSE, WHICH POSSESSES OSTEO-INDUCTIVE, OSTEO-CONDUCTIVE POTENTIAL AND EXCELLENT HANDLING PROPERTIES. IN PLASTIC AND RECONSTRUCTIVE SURGERY (PRS), MTF LAUNCHED FLEXHD PRE, AN INNOVATIVE TISSUE FORM, DESIGNED TO ALLOW SURGEONS GREATER OPTIONS FOR BREAST RECONSTRUCTION PROCEDURES FOLLOWING MASTECTOMY. THE MTF PRS DIVISION ALSO SAW AN INCREASED USE OF RENUVA, AN ADIPOSE MATRIX, FOR USES SUCH AS RECONSTRUCTION AND TREATMENT OF SMALL VOLUME DEFECTS WHERE HOST FAT HAS EITHER DECREASED OR BEEN DEGRADED OR LOST DUE TO TRAUMA OR DISEASE. MTF'S WOUND CARE DIVISION DEVELOPED AND LAUNCHED SOMAGEN, AN ACELLULAR DERMAL ALLOGRAFT AND LENEVA A SOFT TISSUE ADIPOSE MATRIX. MTF ALSO CONTINUED EXPANDING THE DISTRIBUTION OF ITS WOUND CARE PORTFOLIO TO MORE RECIPIENTS IN THE VA AND PUBLIC HOSPITALS THROUGHOUT THE YEAR. MTF CONTINUED TO EXPAND ITS CLINICAL STUDY PORTFOLIO, INCREASING ITS COMPENDIUM OF CLINICAL DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND BREAST RECONSTRUCTION. MTF CONTINUED ITS PROSPECTIVE RANDOMIZED CLINICAL TRIAL FOR FLEXHD PLIABLE ACELLULAR DERMAL MATRIX FOR USES SUCH AS BREAST RECONSTRUCTION FOLLOWING MASTECTOMY. IN THE WOUND CARE MARKET, CLINICAL STUDIES AND RESEARCH DATA HAVE PROVIDED THE INFORMATION FOR MTF TO ATTAIN COVERAGE FOR APPROXIMATELY 73% OF ALL COVERED AMERICAN LIVES IN 2019. MTF CONTINUED ITS SUPPORT OF THE AMERICAN SOCIETY OF PLASTIC SURGEONS (ASPS) AND THE PLASTIC SURGERY FOUNDATION (PSF) WHICH PROVIDES OPPORTUNITIES FOR SURGEONS TO PERFORM ALLOGRAFT BASED RESEARCH TO ADVANCE THE SCIENCE OF ALLOGRAFT USE IN PLASTIC/RECONSTRUCTIVE PROCEDURES. MTF ALSO REMAINS COMMITTED TO SUPPORTING BREAST RECONSTRUCTION AWARENESS (BRA) DAY EACH YEAR AND INCLUDES EDUCATION FOR BOTH PATIENTS AND SURGEONS ON THE OPTIONS AVAILABLE TODAY FOR WOMEN, HELPING TO ENSURE SURVIVORS' RIGHTS TO MAKE AN INFORMED DECISION. MTF ALSO CONTINUED ITS FINANCIAL PLEDGE OF (1M OVER FIVE YEARS) TO SUPPORT BIOLOGIC RESEARCH THROUGH THE PLASTIC SURGERY FOUNDATION (PSF). MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS. |
| FORM 990, PART V, LINE 4B | CANADA |
| FORM 990, PAGE 6, PART VI, LINE 6 | MTF IS ORGANIZED WITH TWO CLASSES OF MEMBERSHIP WHICH ARE (1) NON- CORPORATE MEMBERSHIP AND (2) CORPORATE MEMBERSHIP. THE NON-CORPORATE MEMBERS INCLUDE ACADEMIC MEMBERS, RECOVERY MEMBERS AND RESEARCH MEMBERS. THE SOLE CORPORATE MEMBER OF MTF IS BIOCON, INC. |
| FORM 990, PAGE 6, PART VI, LINE 7A | THE SOLE CORPORATE MEMBER MAY APPOINT ALL DIRECTORS SUBJECT TO THE FOLLOWING: THE CURRENT CHAIRPERSON AND VICE CHAIR OF MTF'S "MEDICAL BOARD OF TRUSTEES" WILL BE APPOINTED TO THE BOARD. ALSO, THE CURRENT CHAIRPERSON AND VICE CHAIR OF MTF'S "DONATION BOARD OF TRUSTEES" WILL BE APPOINTED MEMBERS OF THE BOARD OF DIRECTORS. |
| FORM 990, PAGE 6, PART VI, LINE 7B | ANY CHANGES THAT ARE A MATERIAL CHANGE TO THE GOVERNING DOCUMENTS OF THE FOUNDATION (EX.BY-LAWS OR ARTICLES OF INCORPORATION) MUST BE APPROVED BY THE MEMBERS OF THE FOUNDATION'S MEDICAL BOARD OF TRUSTEES AND THE DONATION BOARD OF TRUSTEES. FINAL APPROVAL OF THESE CHANGES MUST BE APPROVED BY THE BOARD OF DIRECTORS. |
| FORM 990, PAGE 6, PART VI, LINE 11B | MEMBERS OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS WERE PROVIDED WITH A COPY OF FORM 990. THE 990 WAS REVIEWED AT AN OPEN MEETING OF THE AUDIT COMMITTEE. SUBSEQUENT TO MODIFICATIONS, IF ANY, AS A RESULT OF THE AUDIT COMMITTEE MEETING, THE FORM 990 IS THEN CIRCULATED TO ALL MEMBERS OF THE BOARD OF DIRECTORS FOR THEIR FINAL REVIEW AND APPROVAL BEFORE FILING. |
| FORM 990, PAGE 6, PART VI, LINE 12C | MTF SENDS A COMPREHENSIVE QUESTIONNAIRE ANNUALLY TO BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES REQUESTING DISCLOSURE OF ANY CONFLICTS OF INTEREST. MTF IS DILIGENT IN REVIEWING THE ANNUAL DISCLOSURE FORMS SUBMITTED BY THE COVERED PERSONS, AND IN SCREENING, COMPILING AND MAINTAINING THE SUBMISSIONS. |
| FORM 990, PAGE 6, PART VI, LINE 15A | EXECUTIVE COMPENSATION REVIEW: EACH YEAR, MTF REVIEWS AND ASSESSES THE REASONABLENESS OF TOTAL COMPENSATION ARRANGEMENTS FOR OUR EXECUTIVE TEAM, INCLUDING THE CEO. THE ANALYSIS INCORPORATES COMPENSATION SURVEY DATA, LAST COMPILED IN SEPTEMBER 2020, FORM 990'S OF COMPANIES OF RELATED INDUSTRIES AND SIMILAR SIZE. A BLEND OF BOTH FOR-PROFIT AND NOT-FOR-PROFIT COMPANIES IS USED. EVERY THIRD YEAR (MOST RECENTLY SEPTEMBER 2020), MTF RETAINS THE SERVICES OF AN INDEPENDENT COMPENSATION CONSULTANT TO ASCERTAIN AND DETERMINE THAT MTF IS PAYING AND PROVIDING A REASONABLE TOTAL COMPENSATION PACKAGE TO THEIR EXECUTIVES AND TO PROVIDE AN OPINION LETTER OF THEIR FINDINGS. COMPENSATION COMMITTEE REVIEW MTF'S BOARD OF DIRECTORS ESTABLISHED A COMPENSATION COMMITTEE IN 1995. THE RESPONSIBILITY OF THE COMMITTEE INCLUDES THE REVIEW AND APPROVAL OF EXECUTIVE AND STAFF COMPENSATION AND BENEFITS. THE COMPENSATION COMMITTEE TYPICALLY MEETS SEMI-ANNUALLY TO REVIEW MERIT AND BONUS RECOMMENDATIONS. A COPY OF THE COMPENSATION COMMITTEE'S CHARTER, AGENDAS, MEETING MATERIALS, AND MEETING MINUTES ARE MAINTAINED. |
| FORM 990, PAGE 6, PART VI, LINE 15B | THE PROCESS IS THE SAME AS DESCRIBED ABOVE IN LINE 15A. |
| FORM 990, PAGE 6, PART VI, LINE 19 | MTF MAKES ITS FORM 990 AND OTHER PUBLIC DOCUMENTS AVAILABLE TO THE PUBLIC AT ITS REGULAR PLACE OF BUSINESS IN PERSON, REQUESTS THROUGH EMAIL OR VIA US POSTAL SERVICE. IN ADDITION FORM 990 IS AVAILABLE ON THE INTERNET AT WWW.GUIDESTAR.ORG. |
| FORM 990, PART XI, LINE 9 | UNREALIZED FOREIGN EXCHANGE 675,161 ACCRUED GRANTS -852,403 BOOK / TAX DEPRECIATION DIFFERENCE 7,583,333 TOTAL 7,406,091 |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOCON INC | |||||||||||
| 125 MAY STREET | EDISON | NJ | 08837 | 223619257 | HOLDING CO | DC | 501C3 | 12B | NA | false | |
| DEUTSCHES INSTITUT FUR ZELL-UND | |||||||||||
| C/O BIOCON INC 125 MAY STREET | EDISON | NJ | 08837 | TISSUE DIS | BIOCON INC | false | GM | ||||
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | DEUTSCHES INSTITUT FUR ZELL-UND | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | C/O BIOCON INC 125 MAY STREET | AddressLine1Txt |
| City | EDISON | CityNm |
| State Abbreviation | NJ | StateAbbreviationCd |
| ZIP | 08837 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Activities | TISSUE DIS | PrimaryActivitiesTxt |
| Direct Controlling NA | N/A | DirectControllingNACd |
| Controlled Organization | false | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | Yes (true) | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | Yes (true) | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | Yes (true) | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | Yes (true) | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | Yes (true) | TransferToOtherOrgInd |
| Transfer From Other Org | Yes (true) | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (8 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| DIZG GMBH | ||
| A | $5,402 | ACCTG BOOKS/RECORDS |
| DIZG GMBH | ||
| G | $400,755 | ACCTG BOOKS/RECORDS |
| DIZG GMBH | ||
| S | $442,182 | ACCTG BOOKS/RECORDS |
| BIOCON INC | ||
| A | $128,581 | ACCTG BOOKS/RECORDS |
| BIOCON INC | ||
| K | $3,223,664 | ACCTG BOOKS/RECORDS |
| BIOCON INC | ||
| L | $487,608 | ACCTG BOOKS/RECORDS |
| BIOCON INC | ||
| S | $410,919 | ACCTG BOOKS/RECORDS |
| BIOCON INC | ||
| R | $790,500 | ACCTG BOOKS/RECORDS |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE R | FormAndLineReferenceDesc |
| Explanation | BIOCON INC, A TAX-EXEMPT ORGANIZATION SERVES AS THE SOLE CORPORATE MEMBER OF MTF. BIOCON THROUGH ITS DISREGARDED ENTITIES OWNS OPERATES AND LEASES PROPERTY TO MTF. SCHEDULE R, PART II AND PART IV: DIZG, GMBH HAS BEEN DETERMINED TO HAVE SOME TAX-EXEMPT ACTIVITIES AS WELL AS SOME TAXABLE ACTIVITIES IN GERMANY. THUS, DIZG IS SHOWN AS BOTH AN EXEMPT AND TAXABLE ORGANIZATION ON SCHEDULE R. DIZG IS A BROTHER/SISTER ENTITY RELATIVE TO MTF AND IS WHOLLY OWNED BY BIOCON, INC. SCHEDULE R, PART V, LINE 2(2) AND 2(3): DURING 2020, MTF DISTRIBUTED DONORS TO DIZG IN THE AMOUNT OF 400,755. DIZG ALSO REPAID MTF OUTSTANDING ADVANCES TOTALING 442,182 GIVEN THESE CIRCUMSTANCES NO FORM 926 WAS DEEMED NECESSARY. | ExplanationTxt |